FARALLON CAPITAL MANAGEMENT LLC - ZEALAND PHARMA A S ownership

ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 17 filers reported holding ZEALAND PHARMA A S in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of ZEALAND PHARMA A S
ValueSharesWeighting
Q1 2022$7,747,000
-28.8%
496,890
-2.6%
0.04%
-31.5%
Q4 2021$10,883,000
-23.9%
510,0000.0%0.05%
-19.4%
Q3 2021$14,306,000
-5.1%
510,0000.0%0.07%
+8.1%
Q2 2021$15,071,000
-7.5%
510,0000.0%0.06%
-23.5%
Q1 2021$16,300,000
-11.1%
510,0000.0%0.08%
-26.4%
Q4 2020$18,329,000
-4.5%
510,000
+1.0%
0.11%
-17.3%
Q3 2020$19,190,000
+9.7%
505,000
+1.0%
0.13%
-5.0%
Q2 2020$17,500,000
-32.4%
500,000
-33.3%
0.14%
-36.9%
Q1 2020$25,875,000
-22.8%
750,000
-25.7%
0.22%
-1.8%
Q4 2019$33,525,000
+30.9%
1,009,800
-0.0%
0.23%
+17.1%
Q3 2019$25,614,000
+18.9%
1,010,000
+1.0%
0.19%
+37.9%
Q2 2019$21,550,000
+33.5%
1,000,000
+5.4%
0.14%
+15.7%
Q1 2019$16,147,000
+54.5%
948,700
+5.4%
0.12%
+57.1%
Q4 2018$10,449,000
-29.7%
900,0000.0%0.08%
-12.5%
Q3 2018$14,868,000
+30.3%
900,0000.0%0.09%
+25.7%
Q2 2018$11,412,000
-12.2%
900,000
+4.0%
0.07%
-22.2%
Q1 2018$12,992,000
+47.0%
865,000
+33.1%
0.09%
+25.0%
Q4 2017$8,840,000
-29.2%
650,0000.0%0.07%
-35.1%
Q3 2017$12,480,000650,0000.11%
Other shareholders
ZEALAND PHARMA A S shareholders Q1 2021
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 48,957$631,0000.10%
GOLDMAN SACHS GROUP INC 500,916$6,517,0000.00%
BANK OF AMERICA CORP /DE/ 220,523$2,869,0000.00%
WELLS FARGO & COMPANY/MN 100$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
US BANCORP \DE\ 509$7,0000.00%
CREDIT SUISSE AG/ 285$4,0000.00%
MORGAN STANLEY 6,705$87,0000.00%
UBS Group AG 351$4,0000.00%
JANE STREET GROUP, LLC 23,976$312,0000.00%
View complete list of ZEALAND PHARMA A S shareholders